rhinovirus RNA dependent RNA polymerase inhibitors (Cocrystal Pharma)

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug Namerhinovirus RNA dependent RNA polymerase inhibitors (Cocrystal Pharma)
Drug Alias NameBroad-Spectrum Antivirals (Biozone/Cocrystal)Broad-Spectrum Antivirals (Cocrystal Discovery)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionBacterial DNA-directed RNA polymerase inhibitors
TargetsBacterial DNA-directed RNA polymerase
Therapy Area/IndicationsRhinovirus infection
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesCocrystal Discovery Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesCocrystal Discovery IncCocrystal Pharma Inc
Active IndicationsN/A
Inactive IndicationsRhinovirus infection

Other Information

ATC CodeN/A
Related LinksN/A